Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 6, 2008, Pages 557-563

  Jarvis, Kelly ^a   DelBello, Melissa P ^a   Mills, Neil ^a   Elman, Igor ^b   Strakowski, Stephen M ^a   Adler, Caleb M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN; BRAIN REGION; BRAIN SIZE; CANNABIS ADDICTION; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; MORPHOMETRICS; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADOLESCENT; BIPOLAR DISORDER; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; PILOT PROJECTS;

EID: 58149120755     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.033     Document Type: Article

References (54)

1. Adler CM, Levine AD, DelBello MP, Strakowski SM: Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 58:151-157, 2005.
2. th edition (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
3. Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS: Cannabis use and brain structural alterations in first episode schizophrenia - a region of interest, voxel based morphometric study. Schizophr Res 99:1-6, 2008.
4. Block RI, O'Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, Arndt S, Hall JA: Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 11:491-496, 2000.
5. Blumberg HP, Charney DS, Krystal JH: Frontotemporal neural systems in bipolar disorder. Semin Clin Neuropsychiatry 7:243-254, 2002.
6. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC, Charney DS, Gore JC, Krystal JH, Peterson BS: A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60:601-609, 2003.
7. Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS: Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. Biol Psychiatry 59:611-618, 2006.
8. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE: Acute effects of cocaine on human brain activity and emotion. Neuron 19:591-611, 1997.
9. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED: Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 55:77-84, 2004.
10. Cahill CM, Malhi GS, Ivanovski B, Lagopoulos J, Cohen M: Cognitive compromise in bipolar disorder with chronic cannabis use: Cause or consequence? Expert Rev Neurother 6:591-598, 2006.
11. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A: Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: A functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61:781-792, 2004.
12. Chang K, Adleman N, Wagner C, Barnea-Goraly N, Garrett A: Will neuroimaging ever be used to diagnose pediatric bipolar disorder? Dev Psychopathol 18:1133-1146, 2006.
13. DeBellis MD, Clark DB, Beers SR, Soloff PH, Boring AM, Hall J, Kersh A, Keshavan MS. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry 157:737-744, 2000.
14. DeBellis MD, Narasimhan A, Thatcher DL, Keshavan MS, Soloff P, Clark DB. Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res 29:1590-1600, 2005.
15. DelBello MP, Strakowski SM, Sax KW, McElroy SL, Keck PE Jr, West SA, Kmetz GF: Familial rates of affective and substance use disorders in patients with first-episode mania. J Affect Disord 56:55-60, 1999.
16. DelBello MP, Adler CM, Strakowski SM: The neurophysiology of childhood and adolescent bipolar disorder. CNS Spectr 11:298-311, 2006.
17. DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM: Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 164:582-590, 2007.
18. Delisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K, Bappal A, Ardekani BA: A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct J 3:17, 2006.
19. Feinman JA, Dunner DL: The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 37:43-49, 1996.
20. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, version 2.0). New York, New York State Psychiatric Institute, Biometrics Research Department, 1995.
21. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, O'Brien CP, Childress AR: Decreased gray matter in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 51:134-142, 2002.
22. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 2:189-210, 1995.
23. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL, DelBello MP, Soutullo C: Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 40:450-455, 2001.
24. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652, 2002.
25. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS: A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21-36, 2001.
26. Hyman SE, Malenka RC, Nestler EJ: Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598, 2006.
27. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR: Impact of cannabis use on brain function in adolescents. Ann NY Acad Sci 1021:384-390, 2004.
28. Kalivas PW, Volkow ND: The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162:1403-1413, 2005.
29. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-up Evaluation. Arch Gen Psychiatry 44:540-548, 1987.
30. Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J: Imaging gene-substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett 405:196-201, 2006.
31. Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L: Substance abuse and onset of psychotic illness. Hosp Community Psychiatry 44:567-571, 1993.
32. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT: Automated Talairach Atlas labels for functional brain mapping. Hum Brain Mapp 10:120-131, 2000.
33. Lingford-Hughes AR, Davies SJ, McIver S, Williams TM, Daglish MR, Nutt DJ: Addiction. Br Med Bull 65:209-222, 2003.
34. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF: Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) 184:139-144, 2006.
35. Majewska, MD: Cocaine addiction as a neurological disorder: Implications for treatment. NIDA Res Monogr 163:1-26, 1996.
36. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M: The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 9:199-213, 1992.
37. Miller NS, Goldsmith RJ: Craving for alcohol and drugs in animals and humans: Biology and behavior. J Addict Dis 20:87-104, 2001.
38. Modell JG, Mountz JM: Focal cerebral blood flow change during craving for alcohol measured by SPECT. J Neuropsychiatry Clin Neurosci 7:15-22, 1995.
39. Morris NM, Udry JR: Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc Dev 9:271-280, 1980.
40. Pascual-Leone A, Dhuna A, Anderson DC: Cerebral atrophy in habitual cocaine abusers: A planimetric CT study. Neurology 41:34-38, 1991.
41. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Mathalon DH, Lim KO: A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 55:905-912, 1998.
42. Quickfall J, Crockford D: Brain neuroimaging in cannabis use: A review. J Neuropsychiatry Clin Neurosci 18:318-332, 2006.
43. Rais M, Cahn W, Van Haren N, Schnack H, Caspers E, Hulshoff Pol H, Kahn R: Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 165:490-496, 2008.
44. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511-2518, 1990.
45. Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, Fisch HU, Pearlson GD: Decreased frontal white-matter volume in chronic substance abuse. Int J Neuropsychopharmacol 9:147-153, 2006.
46. Strakowski SM, McElroy SL, Keck PE Jr, West SA: The effects of antecedent substance abuse on the development of first-episode psychotic mania. J Psychiatr Res 30:59-68, 1996.
47. Strakowski SM, Sax KW, McElroy SL, Keck PE Jr, Hawkins JM, West SA: Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry 59:465-471, 1998.
48. Strakowski SM, DelBello MP, Fleck DE, Arndt S: The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 48:477-485, 2000a.
49. Strakowski SM, DelBello MP, Adler C, Cecil DM, Sax KW: Neuroimaging in bipolar disorder. Bipolar Disord 2:148-164, 2000b.
50. Wilens TE, Biederman J, Millstein RB, Wozniak J, Hahesy AL, Spencer TJ: Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 38:680-685, 1999.
51. Wilens TE, Biederman J, Kwon A, Ditterline J, Forkner P, Moore H, Swezey A, Snyder L, Henin A, Wozniak J, Faraone SV: Risk of substance use disorders in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 43:1380-1386, 2004.
52. Wilke M, Kaufmann C, Grabner A, Pütz B, Wetter TC, Auer DP: Gray matter changes and correlates of disease severity in schizophrenia: A statistical parametric mapping study. Neuroimage 13:814-824, 2001.
53. Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J: Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. J Addict Dis 19:1-22, 2000.
54. Winokur G, Coryell W, Akiskal HS, Maser JD, Keller MB, Endicott J, Mueller T: Alcoholism in manic-depressive (bipolar) illness: Familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry 152:365-72, 1995.